<DOC>
	<DOCNO>NCT02822716</DOCNO>
	<brief_summary>The objective study study safety effect IRE treatment inoperable hepatic pancreatic malignancy .</brief_summary>
	<brief_title>Irreversible Electroporation Inoperable Hepatic Pancreatic Malignancy</brief_title>
	<detailed_description>Irreversible electroporation ( IRE ) form non-thermal local ablation solid tumor , induces apoptosis tumor cell create irreversible damage cell membrane use electric current . The use thermal ablation tumor adjacent major blood vessel advisable `` heat-sink effect '' owe blood vessel render thermal treatment effective . On hand , application thermal ablation tumor adjacent blood vessel bile duct cause thermal damage structure . It show animal experiment IRE effective causing cell death blood vessel , bile duct , nerve vicinity preserve . Early evidence clinical study show IRE reasonably safe effective treatment pancreatic hepatic tumor .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Inclusion criterion hepatic malignancy : 1 . Signed informed consent patient 2 . Age 18 year 3 . ChildPugh A B cirrhosis 4 . Eastern Cooperative Oncology Group performance ( ECOG ) score 2 5 . No serious concurrent medical illness 6 . Histologically cytologically proven malignant liver tumor , lesion size 1 2 cm , typical feature hepatocellular carcinoma ( HCC ) two dynamic image technique , lesion large 2cm , typical feature one dynamic image technique , lesion large 2cm Apha Fetal Protein ( AFP ) level &gt; 200 ug/L 7 . Inoperable HCC due patient tumor factor , without extrahepatic involvement Chest Xray ( CXR ) CT 8 . Massive expansive tumor type HCC measurable lesion CT 9 . Recurrent intrahepatic HCC surgical resection local ablation 10 . Metastatic liver tumor welldefined margin 11 . Tumor size &lt; = 3cm large dimension 12 . Tumor number &lt; = 3 Inclusion criterion pancreatic malignancy : 1 . Signed informed consent patient 2 . Age old 18 year . 3 . Any kind histologically radiologically diagnose malignant pancreatic tumor . 4 . Tumor size &lt; = 3cm large dimension 5 . Surgical treatment consider option patient factor tumor factor , vascular encasement regional lymph node metastasis 6 . Locally recurrent pancreatic tumor surgical resection 7 . Karnofsky 's performance status 50 % great . 8 . Life expectancy great 3 month . 9 . Normal coagulation profile ( INR &lt; 1.5 ; platelet count &gt; 50 10^9/L ) . 10 . Willingness ability complete followup interview image investigation follow treatment . Exclusion criterion hepatic malignancy : 1 . History prior malignancy except condition patient disease free â‰¥3 year 2 . Concurrent ischemic heart disease heart failure 3 . Biliary obstruction amenable percutaneous drainage 4 . ChildPugh C cirrhosis 5 . Intractable ascites controllable medical therapy 6 . History variceal bleeding within last 3 month ; serum total bilirubin level &gt; 50 umol/L 7 . Serum albumin level &lt; 25g/L 8 . INR &gt; 1.5 , platelet count &lt; 50 10^9/L 9 . Infiltrative diffuse tumor 10 . Hepatic vein tumor thrombus 11 . Pregnancy 12 . Cardiac arrhythmia 13 . Uncontrolled hypertension Exclusion Criteria pancreatic malignancy : 1 . Patient active infection . 2 . Patient bleeding tendency . 3 . Presence portal vein thrombus . 4 . Tumour size great dimension &gt; 3cm . 5 . Tumor ill define infiltrative margin . 6 . The tumor invade duodenal wall . 7 . Presence distant metastasis 8 . Currently experience episode major mental illness ( psychosis , major affective disorder , schizophrenia ) . 9 . Pregnancy 10 . Cardiac arrhythmia 11 . Uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>